22
staff
Ayodola Anise
Ayodola Anise is the senior director of operations working across FasterCures, Center for Public
Health, Center for the Future of Aging, and Feeding Change.
+ Read More
report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More
report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering 
;the market and can identify multiple cancers early and simultaneously.
+ Read More
report
Landscape of Trust: Health Data Frameworks
The rapid advancement of the health technology landscape relies heavily on patient data.
report
A Global Early Warning System for Pandemics: Perspectives from the Front Lines
The COVID-19 pandemic exposed critical gaps in the world’s ability to detect, track, and analyze pa
ndemic threats.
+ Read More
report
Mapping the Journey: Building a Mutual Understanding for Health Equity in Clinical Research
If the objective of biomedical research is to spur innovation to create healthier communities, exte
nd life, and more effectively treat or cure disease, then persistent inequities run counter to that goal and create unnecessary barriers to health and wel
+ Read More
report
Community-Based Infrastructure for Inclusive Research: Engaging the Private Sector
Clinical trial networks, as evidenced during the COVID-19 pandemic, really are “national critical i
nfrastructure.” The pandemic revealed prominent gaps and stark differences in health outcomes across various populations.
+ Read More
report
Data Governance for Early Warning Systems
The COVID-19 pandemic resulted in the proliferation of new data that have created unprecedented opp
ortunities to establish early warning systems for pandemics.
+ Read More
report
Toward a National Action Plan for Achieving Diversity in Clinical Trials
Participation in clinical research among racial and ethnic minorities remains low, even though such
groups now represent nearly 40 percent of the US population.
+ Read More
video
The Impact of Investing in Health Equity in Biomedical Research
October 20 at 8:30 am PDT / 11:30 am EDT
Biomedical research relies on commercial investmen
t, grant funding, and private donations to accelerate drug development, run clinical trials, and support innovation in health technologies.
+ Read More
video
Virtual Program | A Conversation with Marcella Nunez-Smith on COVID-19 and Health Equity
October 19 at 10:00 am PDT / 1:00 pm EDT
Guest
Marcella Nunez-Smith
article
Milken Institute Announces Key Initiatives at the 2024 Global Conference to Shape the Future of Health
Esther Krofah, executive vice president of Milken Institute Health, (pictured at left) with Emma Wal
msley, CEO of GSK, (right) at the 2024 Milken Institute Global Conference.
+ Read More